Clinical Accelerator is a global clinical trial management organisation supporting med-tech, med-dev, and life science innovators as they progress from prototype to human studies.
For their 2025 Clinical Accelerator Program, the team needed to rapidly identify and engage early-stage companies approaching clinical readiness—those likely to be candidates for their upcoming cohort.
Clinical Accelerator partnered with Prospero AI to build and deploy a high-precision, time-sensitive outbound system designed to surface innovators on the brink of clinical milestones.
The brief was simple:
Find the right companies, at the right time, and deliver the right message—fast.
In a one-off engagement (rather than our typical 3-month cycles), Prospero AI delivered:
The Clinical Accelerator team faced several constraints:
The task was clear:
Identify and engage companies globally that are either preparing to start clinical trials or publicly signalling imminent trial activity.
Prospero AI aggregated data from:
We built a universe of companies across:
Then we refined this universe to identify only those showing clinical-readiness signals, such as:
This resulted in a hyper-targeted dataset of innovators who were not just relevant—but timely.
Total candidates surfaced: thousands globally
Final qualified outreach list: tightly filtered for clinical-stage momentum
Every outreach sequence ran through Prospero AI’s Research + Copywriting agents.
Each message included:
This wasn’t template-based messaging.
It was scientifically aware, stage-specific outreach that communicated relevance immediately.
To ensure maximum inbox placement for such a time-critical campaign:
Even within a rapid deployment window, Prospero ensured optimal sending reputation from day one.
In less than 30 days:
60 qualified, clinical-ready organisations responded with interest
Strong alignment to Clinical Accelerator’s cohort criteria
Velocity equivalent to the output of an internal team of 2–3 SDRs
Reply sentiment heavily skewed toward “interested” and “let’s discuss”
Examples of high-intent responses included:
Interest from founders, CEOs, and regulatory/clinical leaders
Prospero AI enabled Clinical Accelerator to fill their 2025 cohort pipeline far ahead of schedule, giving their team a strong, qualified pool to engage.
Outreach connected with companies at exactly the right inflection point—leading to accelerated engagement and deeper discussions.
Prospero AI handled the entire operation:
Clinical Accelerator simply reviewed the inbound leads and booked calls.
The completed system can be replicated and extended for:
Continuous pipeline generation
Prospero AI equipped Clinical Accelerator with a precision-engineered, time-sensitive outbound system that delivered 60 qualified clinical-ready leads in under 30 days during a one-off engagement.
This project is a perfect demonstration of Prospero AI’s core mission:
Let the client just click send.
Everything else—data, research, personalisation, infrastructure, optimisation—is handled for you.
Life Trade partnered with Prospero AI to design, execute, and optimise a complete outbound strategy-covering targeting, research, messaging, deliverability infrastructure, and reporting.
